Functionalization of mesoporous silicon nanoparticles for targeting and bioimaging purposes

Journal of Nanomaterials

Volumn 2012, Issue , 2012, Pages

  Rytkönen, Jussi ^a,b   Miettinen, Riitta ^a,c   Kaasalainen, Martti ^d   Lehto, Vesa Pekka ^a   Salonen, Jarno ^d   Närvänen, Ale ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Biocenter Kuopio   (Finland)

^c CNServices Ltd   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIO-IMAGING; CARBOXYL GROUPS; FUNCTIONALIZATIONS; FUNCTIONALIZED; GLUTATHIONE-S-TRANSFERASE; HUMAN PLASMAS; HYDROPHOBIC INTERACTIONS; IN-VITRO; IN-VIVO; MESOPOROUS SILICON; NANOPARTICLE SUSPENSION; PHYSIOLOGICAL ENVIRONMENT; SILICON NANOPARTICLES; SUSTAINED RELEASE;

BLOOD VESSELS; CARBOXYLIC ACIDS; NANOPARTICLES; POLYETHYLENE GLYCOLS; POROUS SILICON; RADIOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY;

SYNTHESIS (CHEMICAL);

EID: 84866156953     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2012/896562     Document Type: Article

References (35)

1. Bayliss S. C., Heald R., Fletcher D. I., Buckberry L. D., Culture of mammalian cells on nanostructured silicon. Advanced Materials 1999 11 4 318 321 2-s2.0-0033522041 10.1002/(SICI)1521-4095(199903)11:4318::AID-ADMA318>3.0. CO;2-Z
2. Salonen J., Kaukonen A. M., Hirvonen J., Lehto V. P., Mesoporous silicon in drug delivery applications. Journal of Pharmaceutical Sciences 2008 97 2 632 653 2-s2.0-39749159993 10.1002/jps.20999 (Pubitemid 351293873)
3. Limnell T., Riikonen J., Salonen J., Kaukonen A. M., Laitinen L., Hirvonen J., Lehto V. P., Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles. International Journal of Pharmaceutics 2007 343 1-2 141 147 2-s2.0-34548238829 10.1016/j.ijpharm.2007.05. 010 (Pubitemid 47321019)
4. Owens D. E. III, Peppas N. A., Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. International Journal of Pharmaceutics 2006 307 1 93 102 2-s2.0-28844488494 10.1016/j.ijpharm.2005.10.010 (Pubitemid 41773257)
5. Frank M. M., Fries L. F., The role of complement in inflammation and phagocytosis. Immunology Today 1991 12 9 322 326 2-s2.0-0025781819
6. Moghimi S. M., Hunter A. C., Murray J. C., Long-circulating and target-specific nanoparticles: theory to practice. Pharmacological Reviews 2001 53 2 283 318 2-s2.0-0034996764 (Pubitemid 32476118)
7. Geng Y., Dalhaimer P., Cai S., Tsai R., Tewari M., Minko T., Discher D. E., Shape effects of filaments versus spherical particles in flow and drug delivery. Nature Nanotechnology 2007 2 4 249 255 2-s2.0-34248402413 10.1038/nnano.2007.70 (Pubitemid 46739812)
8. Huang R. B., Mocherla S., Heslinga M. J., Charoenphol P., Eniola-Adefeso O., Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review). Molecular Membrane Biology 2010 27 4-6 190 205 2-s2.0-77954492820 10.3109/09687688.2010.499548
9. Levchenko T. S., Rammohan R., Lukyanov A. N., Whiteman K. R., Torchilin V. P., Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating. International Journal of Pharmaceutics 2002 240 1-2 95 102 2-s2.0-0037142255 10.1016/S0378-5173(02)00129- 1 (Pubitemid 34607706)
10. Heurtault B., Saulnier P., Pech B., Proust J. E., Benoit J. P., Physico-chemical stability of colloidal lipid particles. Biomaterials 2003 24 23 4283 4300 2-s2.0-0038309868 10.1016/S0142-9612(03)00331-4 (Pubitemid 36814076)
11. Gref R., Minamitake Y., Peracchia M. T., Trubetskoy V., Torchilin V., Langer R., Biodegradable long-circulating polymeric nanospheres. Science 1994 263 5153 1600 1603 2-s2.0-23444444512 (Pubitemid 24128361)
12. Milton Harris J., Martin N. E., Modi M., Pegylation: a novel process for modifying pharmacokinetics. Clinical Pharmacokinetics 2001 40 7 539 551 2-s2.0-17844380498 (Pubitemid 32738660)
13. Faure A. C., Dufort S., Josserand V., Perriat P., Coll J. L., Roux S., Tillement O., Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings. Small 2009 5 22 2565 2575 2-s2.0-73349127843 10.1002/smll.200900563
14. Peer D., Karp J. M., Hong S., Farokhzad O. C., Margalit R., Langer R., Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology 2007 2 12 751 760 2-s2.0-36849067019 10.1038/nnano.2007.387 (Pubitemid 350223348)
15. Ruoslahti E., Bhatia S. N., Sailor M. J., Targeting of drugs and nanoparticles to tumors. Journal of Cell Biology 2010 188 6 759 768 2-s2.0-77949762340 10.1083/jcb.200910104
16. 111In-labeled monoclonal antibodies. Nuclear Medicine and Biology 2010 37 8 957 964 2-s2.0-78049456673 10.1016/j.nucmedbio.2010.03.001
17. Koyama T., Shimura M., Minemoto Y., Nohara S., Shibata S., Iida Y., Iwashita S., Hasegawa M., Kurabayashi T., Hamada H., Kono K., Honda E., Aoki I., Ishizaka Y., Evaluation of selective tumor detection by clinical magnetic resonance imaging using antibody-conjugated superparamagnetic iron oxide. Journal of Controlled Release 2012 159 3 413 418 2-s2.0-84860673311 10.1016/j.jconrel.2012.01.023
18. Bimbo L. M., Sarparanta M., Santos H. A., Airaksinen A. J., Mäkilä E., Laaksonen T., Peltonen L., Lehto V. P., Hirvonen J., Salonen J., Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. ACS Nano 2010 4 6 3023 3032 2-s2.0-77955878419 10.1021/nn901657w
19. Salonen J., Björkqvist M., Laine E., Niinistö L., Stabilization of porous silicon surface by thermal decomposition of acetylene. Applied Surface Science 2004 225 14 389 394 2-s2.0-1342287132 10.1016/j.apsusc.2003.10. 028
20. Kovalainen M., Mönkäre J., Mäkilä E., Salonen J., Lehto V., Herzig K., Järvinen K., Mesoporous Silicon (PSi) for sustained peptide delivery: effect of psi microparticle surface chemistry on peptide YY3-36 Release. Pharmaceutical Research 2012 29 3 837 846 10.1007/s11095-011- 0611-6
21. Russo L., Colangelo F., Cioffi R., Rea I., Stefano D., A mechanochemical approach to porous silicon nanoparticles fabrication. Materials 2011 4 6 1023 10.3390/ma4061023
22. Silvander M., Bergstrand N., Edwards K., Linkage identity is a major factor in determining the effect of PEG-ylated surfactants on permeability of phosphatidylcholine liposomes. Chemistry and Physics of Lipids 2003 126 1 77 83 2-s2.0-0142027084 10.1016/S0009-3084(03)00094-X (Pubitemid 37297967)
23. Sarparanta M., Bimbo L. M., Rytkoänen J., Mäkilä E., Laaksonen T. J., Laaksonen P., Nyman M., Salonen J., Linder M. B., Hirvonen J., Santos H. A., Airaksinen A. J., Intravenous delivery of hydrophobin- functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution. Molecular Pharmaceutics 2012 9 3 654 663 2-s2.0-84858052867 10.1021/mp200611d
24. Matrix Science Ltd., The Mascot search engine. 2010
25. Cerrada-Gimenez M., Häyrinen J., Juutinen S., Reponen T., Jänne J., Alhonen L., Proteomic analysis of livers from a transgenic mouse line with activated polyamine catabolism. Amino Acids 2010 38 2 613 622 2-s2.0-77953035777 10.1007/s00726-009-0420-y
26. Deng Z. J., Liang M., Monteiro M., Toth I., Minchin R. F., Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nature Nanotechnology 2011 6 1 39 44 2-s2.0-78650606928 10.1038/nnano.2010.250
27. UniProt Consortium, UniProt protein database. 2011
28. Teichroeb J. H., Forrest J. A., Jones L. W., Size-dependent denaturing kinetics of bovine serum albumin adsorbed onto gold nanospheres. European Physical Journal E 2008 26 4 411 415 2-s2.0-53349176783 10.1140/epje/i2007- 10342-9
29. Shang W., Nuffer J. H., Dordick J. S., Siegel R. W., Unfolding of ribonuclease a on silica nanoparticle surfaces. Nano Letters 2007 7 7 1991 1995 2-s2.0-34547562693 10.1021/nl070777r (Pubitemid 47197579)
30. Lundqvist M., Sethson I., Jonsson B. H., Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. Langmuir 2004 20 24 10639 10647 2-s2.0-10044277018 10.1021/la0484725
31. Lynch I., Salvati A., Dawson K. A., Protein-nanoparticle interactions: what does the cell see? Nature Nanotechnology 2009 4 9 546 547 2-s2.0-70249136214 10.1038/nnano.2009.248
32. Flick M. J., Du X., Witte D. P., Jiroušková M., Soloviev D. A., Busuttil S. J., Plow E. F., Degen J. L., Leukocyte engagement of fibrin(ogen) via the integrin receptor α M β 2/Mac-1 is critical for host inflammatory response in vivo. Journal of Clinical Investigation 2004 113 11 1596 1606 2-s2.0-2942709937 10.1172/JCI200420741 (Pubitemid 39071683)
33. Tanaka T., Mangala L. S., Vivas-Mejia P. E., Nieves-Alicea R., Mann A. P., Mora E., Han H. D., Shahzad M. M. K., Liu X., Bhavane R., Gu J., Fakhoury J. R., Chiappini C., Lu C., Matsuo K., Godin B., Stone R. L., Nick A. M., Lopez-Berestein G., Sood A. K., Ferrari M., Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Research 2010 70 9 3687 3696 2-s2.0-77951699994 10.1158/0008-5472.CAN-09-3931
34. Steinmetz N. F., Manchester M., PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and Ex vivo. Biomacromolecules 2009 10 4 784 792 2-s2.0-65249114149 10.1021/bm8012742
35. Sheng Y., Yuan Y., Liu C., Tao X., Shan X., Xu F., In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content. Journal of Materials Science: Materials in Medicine 2009 20 9 1881 1891 2-s2.0-68849132706 10.1007/s10856-009-3746-9